The medication shares approximately 94% structural homology with human GLP-1 but incorporates strategic molecular modifications that dramatically extend its duration of action
KEY INGREDIENTS: L-Glutamine, L-arginine, L-ornithine, L-lysine, and glycine are combined in just the right amounts to encourage the release of stored growth hormone and a healthy aging process
By combining appetite control with metabolic support, therapy helps you feel satisfied while gradually losing weight
But among people with diabetes, women are more likely, and some studies have found that women experienced a greater risk reduction when taking GLP-1 diabetes medications
A typical schedule looks like this: Weeks 1-4: 0.25 mg, once weekly Weeks 5-8: 0.5 mg, once weekly Weeks 9-12: 1 mg, once weekly Weeks 13-16: Increase to 1.7 mg, once weekly (as tolerated) Weeks 17+: 2.4 mg, once weekly (maximum dose for Wegovy) Well tailor your dosage based on your response
Functioning through dual activation of GLP-1 and GIP receptors, it presents a multifaceted strategy combating diabetes and weight issues
